Skip to Content
Merck
CN
  • Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.

Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.

Journal of medicinal chemistry (2003-06-27)
Srinivas K Kumar, Erin Hager, Catherine Pettit, Hallur Gurulingappa, Nancy E Davidson, Saeed R Khan
ABSTRACT

A series of boronic-chalcone derivatives were synthesized and tested for antitumor activity against human breast cancer cell lines. The results show the boronic-chalcones are more toxic to breast cancer cells compared to normal breast cells than other known chalcones.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MDM2 Inhibitor, The MDM2 Inhibitor, also referenced under CAS 562823-84-1, controls the biological activity of MDM2.